Notice of Special Interest (NOSI): Research Related to Neuroethical Considerations for Neurological Diseases (NOT-NS-24-073)

Sponsor: National Institute of Neurological Disorders and Stroke

Summer Research Education Experience Program (R25 Clinical Trial Not Allowed) (PAR-24-204)

Sponsor: National Institutes of Health

Award: A project period of up to five years may be requested. Funds may be requested for a minimum of 8 weeks and a maximum of 15 weeks of research education experience each year. Proposed, budgets cannot exceed $125,000 direct costs per year.

Due Date: Multiple due dates; see announcement.

BRAIN Initiative: Brain-Behavior Quantification and Synchronization Transformative and Integrative Models of Behavior at the Organismal Level (U01 Clinical Trial Optional) (RFA-DA-24-040)

Sponsor: National Institutes of Health

Due Date: Multiple due dates; see announcement.

BRAIN Initiative: Brain-Behavior Quantification and Synchronization Transformative and Integrative Models of Behavior at the Organismal Level (U01 Clinical Trials Not Allowed) (RFA-DA-24-041)

Sponsor: National Institutes of Health

Due Date: Multiple due dates; see announcement.

Safety and Efficacy of Amyloid-Beta Directed Antibody Therapy in MCI and Dementia with Evidence of Lewy Body Dementia and Amyloid-Beta Pathology (U01 - Clinical Trial Required) (RFA-NS-25-010)

Sponsor: National Institute of Neurological Disorders and Stroke, National Institute on Aging

Award: Direct Costs cannot exceed $6,700,000 per year. The maximum project period is 7 years. NIH intends to fund one award contingent upon NIH appropriations.

Due Date: LOI due December 24, 2024. Application due January 24, 2025.

NINDS Research Education Opportunities (R25 Clinical Trial Not Allowed) (PAR-24-200)

Sponsor: National Institute of Neurological Disorders and Stroke

Award: Application budgets are are limited to a maximum of $250,000 direct cost per year. The maximum project period is 5 years.

Due Date: Multiple due dates; see announcement.

Notice of Special Interest (NOSI): Promoting Data Reuse for Health Research (NOT-OD-24-096)

Sponsor: National Institutes of Health

Due Date: This Notice of Special Interest (NOSI) solicits competitive revision applications. Multiple due dates; see announcement.

Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial Not Allowed) (PA-24-191)

Sponsor: National Institutes of Health

Due Date: Multiple due dates; see announcement.

Mentored Quantitative Research Development Award (Parent K25 Independent Basic Experimental Studies with Humans Required) (PA-24-192)

Sponsor: National Institutes of Health

Due Date: Multiple due dates; see announcement.

Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial Required) (PA-24-190)

Sponsor: National Institutes of Health

Due Date: Multiple due dates; see announcement.

Notice of Special Interest (NOSI): Administrative Supplements to Promote Diversity for NINDS ADRD Awardees (NOT-NS-24-071)

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)

Due Date: Notice expires February 15, 2027.

Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed) (RFA-TR-24-023)

Sponsor: National Center for Advancing Translational Sciences (NCATS)

Award: The combined budget for direct costs for the two-year project period may not exceed $275,000. No more than $200,000 may be requested in any single year.

Due Date: Multiple due dates; see announcement.

BRAIN Initiative: Data Archives for the BRAIN Initiative (R24 Clinical Trial Optional) (RFA-MH-25-110)

Sponsor: National Institutes of Health

Due Date: Multiple due dates; see announcement.

BRAIN Initiative: Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UG3/UH3 Clinical Trial Optional) (RFA-NS-24-016)

Sponsor: National Institutes of Health

Award: Applicants must not exceed $500,000 in direct costs per year for the UG3 phase and should rarely exceed $1,500,000 direct costs per year for the UH3 phase.

Due Date: Multiple due dates; see announcement.

BRAIN Initiative: Clinical Studies to Advance Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UH3 Clinical Trial Optional) (RFA-NS-24-017)

Sponsor: National Institutes of Health

Due Date: Multiple due dates; see announcement.